What does it take to develop a new genomic surveillance pipeline from scratch?
In this first MalariaGEN Podcast we speak to Dr Cristina Ariani, lead of genomic surveillance operations for Covid-19 at the Wellcome Sanger Institute, about leaving malaria surveillance to help in the UK’s effort to track new variants of Covid-19.
Dr Ariani reflect on:
- Her transition from science to genomic operations
- The challenges of developing a Covid surveillance pipeline at pace
- How innovations in Covid surveillance could be applied to malaria genomics
Listen or download the full interview below (recorded during coronavirus lockdown).
MalariaGEN Podcasts focus on genomic surveillance and drug and insecticide resistance in Plasmodium parasites and Anopheles mosquitoes. They explore how genomic research collaborations and data-sharing are increasing our understanding of how to control and eliminate the disease.
MalariaGEN partners have built the world’s largest reference data resource for the species that cause and transmit malaria.
Register at malariagen.net/join-our-mailing-list-receive-latest-malariagen-news/ to hear about news, events and funding opportunities.
